Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats

Conclusions Experimental MCT-induced PAH may be reduced by HSYA treatment, and the mechanism may involve suppression of inflammation and oxidative stress.
Source: Journal of International Medical Research - Category: Research Authors: Tags: Research Reports Source Type: research
More News: Hypertension | Research